维普期刊资源整合服务平台（V6.5）

178篇 您的检索式：作者名="HICKLIN DJ"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Monoclonal antibodies targeting the VEGF receptor-2 (F1k1/KDR) as an anti-angiogenic therapeutic strategy 显示文摘	Hicklin DJ Zhu Z	1998	Cancer Metastasis Rev1998，17，2：	1
2	Monoclonal antibodies targe-ting the VEGF receptor-2 (Flkl/KDR) as an anti-angiogenic therapeuticstrategy显示文摘	Witte L Hicklin DJ Zhu Z	1998	Cancer Metastasis Rev1998，17，：	1
3	Role of the Vascular Endothelial Growth Factor PathWay in Growth and Angiogenesis显示文摘	Hicklin DJ Ellis LM	2005	Journal of Clinical Ontology2005，23，5：	1
4	Escape of human solid tumors from Tell recognition: molecular mechanisms and functional significance显示文摘	Marincola FM Jaffee EM Hicklin DJ	2000	Adv Immunol2000，74，：	1
5	Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance显示文摘	Marineola FM Jaffee EM Hicklin DJ	2000	Adv lmmunol2000，74，：	1
6	Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts显示文摘	Kozin SV Boucher Y Hicklin DJ	2001	Cancer Res2001，61，3：	1
7	Monoclonal antibodies targeting the VEGF receptor-2 (Flkl/KDR) as an anti-angiogenic therapeutic strategy显示文摘	Witte L Hicklin DJ Zhu Z	1998	Cancer Metastasis Rev1998，17，2：	1
8	Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis显示文摘	Hicklin DJ Ellis LM	2005	J Clin Oncol2005，23，5：	1
9	Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced longtem control of hnman tumor xenografats显示文摘	Kozin SV Boucher Y Hicklin DJ	2001	Cancer Res2001，61，1：	1
10	Effect of p53 status on tumor response to antiangiogenic therapy 显示文摘	Yu JL Rak JW Coomber BL Hicklin DJ Kerbel RS	2002	Science2002，295，5559：	1
11	KDR/FLK-1 is a major regulator endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells显示文摘	Kuriyama S Hicklin DJ	1999	Hepatology1999，30，5：	1
12	The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model显示文摘	Yoshiji H Kuriyama S Hicklin DJ	2001	Hepatology2001，33，4：	1
13	VEGF-targeted therapy: mechanisms of anti-tumour activity显示文摘	Ellis LM Hicklin DJ	2008	Nat Rev Cancer2008，8，8：	1
14	Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors 显示文摘	Casanovas O Hicklin DJ Bergers G	2005	Cancer Cell2005，8，4：	1
15	Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced longterm control of human tumor xenografts显示文摘	Kozin SV Boucher Y Hicklin DJ	2001	Cancer Res2001，61，1：	1
16	VEGF-targeted therapy:mechanisms of anti-turnout activity显示文摘	ELLIS LM HICKLIN DJ	2008	Nat Rev Cancer2008，8，8：	1
17	Pathways mediating resistance to vascular endothelial growth factor-targeted therapy显示文摘	Ellis LM Hicklin DJ	2008	Clin Cancer Res2008，14，：	1
18	VEGF - targeted therapy: mechanisms of anti - tumour activity显示文摘	Ellis LM Hicklin DJ	2008	Nat Rev Cancer2008，8，8：	1
19	HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story显示文摘	Hicklin DJ Marineola FM Ferrone S	1999	Mol Med Today1999，5，4：	1
20	The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model显示文摘	Yoshiji H Kuriyama S Hicklin DJ	2001	Hepatology2001，33，4：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示